Valerie Mizrahi is professorial director of the Institute of Infectious Disease and Molecular Medicine at the University of Cape Town and a Fellow of UCT. She also directs the MRC/NHLS/UCT Molecular Mycobacteriology Research Unit and co-directs the DST/NRF Centre of Excellence for Biomedical TB Research. She was an International Research Scholar of the HHMI from 2000-2010, and a Senior International Research Scholar of the HHMI from 2012-2017. Her research focuses on aspects of the physiology and metabolism of Mycobacterium tuberculosis of relevance to TB drug resistance, mycobacterial persistence and TB drug discovery. As an internationally recognised leader in TB research, Valerie holds an A1 rating from the National Research Foundation. She is a Fellow of the American Academy of Microbiology, African Academy of Science and Royal Society of South Africa, an Associate Fellow of The World Academy of Science, and a Member of the Academy of Science of South Africa. Her major awards include the 2013 Christophe Mérieux Prize from the Mérieux Foundation and Institut de France, the Order of the Mapungubwe (Silver) in 2007 from the State President of South Africa, the 2017 Platinum Medal from the SAMRC, the 2018 Harry Oppenheimer Fellowship, the 2006 Gold Medal of the SA Society for Biochemistry and Molecular Biology, and the 2000 Unesco-L’Oréal For Women in Science Award (Africa & Middle East). She has served on many Scientific Advisory Boards, including the Discovery Expert Group of the Bill & Melinda Gates Foundation, Keystone Symposia, K-RITH, the TB Alliance (New York), NM4TB, iM4TB (EPFL, Switzerland), the ICGEB (Trieste) and the Board of Governors of the Tres Cantos Open Lab Foundation.
Prof Valerie Mizrahi